FPAs are image sensors that convert infrared light into electrical signals to produce real-time thermal images and are widely ...

There is growing demand for smart materials that can change their physical properties in response to various external stimuli ...

Energy Secretary Chris Wright issued the mandate this week as the heat wave strains the region's electrical grid.

The Phase 3 trial compared Roche’s divarasib with treatments sold by Amgen and Bristol Myers in patients with non-small cell ...

The Trump administration’s latest restrictions on private AI model releases is ramping up the push for open-source ...

Guidewire is a dominant vertical SaaS provider in P&C insurance, benefiting from high switching costs and deep industry ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today positive results from the Phase III Krascendo 1 study evaluating divarasib, an investigational next-generation KRAS ...

Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated advanced KRAS G12C non-small cell lung cancer Divarasib showed clinically meaningful improvements in ...

Mendota Juvenile Treatment Center is expanding its capacity and treating girls for the first time as Wisconsin moves to close ...

A research team led by Prof. Hyosang Lee of the Department of Brain Sciences at DGIST has identified TWIK-1, a type of ...

Switch Inc. is kicking off a private funding round led by Andreessen Horowitz that could raise about $2 billion, according to people familiar with the matter.

Summary: Late-onset Alzheimer’s disease represents one of the most pervasive, devastating neurodegenerative crises globally.